Pennsylvania ranks third for lung cancer screening, fourth for treatment in new report
A new American Lung Association report places Pennsylvania third nationally for lung cancer screening and fourth for treatment, with survival above the national average.

In this piece
The American Lung Association says Pennsylvania ranks third in the nation for lung cancer screening and fourth for treatment in a new report. The same…
Pennsylvania ranks third best in the nation for lung cancer screening and fourth best for treatment, according to a new American Lung Association report. The same report finds lung cancer survival in the state above average.
The rankings were reported in a notice circulated through Google News and attributed to the American Lung Association. The short item does not include the underlying tables, state-by-state scores, or the methods used to build the rankings.
Screening is the first measure highlighted. A third-place national ranking means the association placed Pennsylvania near the top of states on whatever screening measure the report uses. The notice does not say which tests, age groups, or insurance settings were counted.
Treatment is the second measure. Fourth best in the nation places Pennsylvania among the stronger states on the report’s treatment measure. The available summary does not define treatment, such as surgery, radiation, systemic therapy, or time to care.
Survival is described only as above average. The notice does not give a survival percentage, a comparison year, or whether the figure is five-year survival or another interval. Readers should treat “above average” as the association’s characterization, not as a newly calculated rate.
The American Lung Association is a long-standing U.S. public-health organization focused on lung disease, including lung cancer. Reports of this kind are typically used by clinicians, advocates, and state officials to compare how states detect and treat the disease. This wire item does not quote any association official or Pennsylvania health authority.
Lung cancer remains a leading cause of cancer death in the United States, which is why screening and treatment access draw close attention from public-health groups. Early detection programs and timely treatment are widely discussed as ways to improve outcomes. Those general points are context; they are not additional findings from this report.
The notice does not say whether Pennsylvania improved, slipped, or held steady compared with an earlier edition. It also does not identify counties, health systems, or demographic groups that drove the statewide ranks. No local geography beyond Pennsylvania is specified.
Because the source is a headline-level summary, gaps remain. It is not possible from this item alone to say how large the gap is between Pennsylvania and the top-ranked states, or how the state compares with its neighbors. Those comparisons would require the full report.
What happens next depends on release of the complete findings. Health departments, cancer centers, and advocacy groups often use such rankings to review screening outreach and treatment capacity. Until the full American Lung Association report is reviewed, the confirmed claims are limited to third for screening, fourth for treatment, and above-average survival.
Primary source: Google News Pennsylvania. Newzly rewrites and structures source reporting for clarity; verify critical details at the original.